Disease Characteristics of HER-2/neu Positive Breast Cancer - Muhammad Bin Saleh Baig, Mirza
46,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
23 °P sammeln
  • Broschiertes Buch

HER-2/neu positive breast cancer is a distinct entity of breast cancer having different treatment options including targeted therapy like trastuzumab and patients can gain maximum benefit from this line of therapy. HER-2/neu receptor status should be checked in every breast cancer patient so that patients can be offered the best possible therapy for their disease. More studies must be conducted on larger scale so that better understanding of this particular subtype can be achieved.

Andere Kunden interessierten sich auch für
Produktbeschreibung
HER-2/neu positive breast cancer is a distinct entity of breast cancer having different treatment options including targeted therapy like trastuzumab and patients can gain maximum benefit from this line of therapy. HER-2/neu receptor status should be checked in every breast cancer patient so that patients can be offered the best possible therapy for their disease. More studies must be conducted on larger scale so that better understanding of this particular subtype can be achieved.
Autorenporträt
Dr. Mirza Muhammad Bin Saleh Baig - Diplôme de M.Sc. Radiation & Medical Oncology, Département des sciences médicales, Pakistan Institute of Engineering & Applied Sciences, Nilore, Islamabad, Pakistan.